Implementation of the Prostate Cancer Prevention Trial (PCPT)

Phyllis J. Goodman; Catherine M. Tangen; John J. Crowley; Susan M. Carlin; Anne Ryan; Charles A. Coltman; Leslie G. Ford; Ian M. Thompson

doi:10.1016/j.cct.2003.11.007

Implementation of the Prostate Cancer Prevention Trial (PCPT)

Phyllis J. Goodman, Catherine M. Tangen, John J. Crowley, Susan M. Carlin, Anne Ryan, Charles A. Coltman, Leslie G. Ford, Ian M. Thompson

Mays Cancer Center

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.

Original language	English (US)
Pages (from-to)	203-222
Number of pages	20
Journal	Controlled Clinical Trials
Volume	25
Issue number	2
DOIs	https://doi.org/10.1016/j.cct.2003.11.007
State	Published - Apr 2004

Keywords

Chemoprevention
Finasteride
Prostate cancer
Study management
Study organization

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/j.cct.2003.11.007

Fingerprint Dive into the research topics of 'Implementation of the Prostate Cancer Prevention Trial (PCPT)'. Together they form a unique fingerprint.

Cite this

@article{9d67533c18354a9fa7cb9cb6ffdd0456,

title = "Implementation of the Prostate Cancer Prevention Trial (PCPT)",

abstract = "The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.",

keywords = "Chemoprevention, Finasteride, Prostate cancer, Study management, Study organization",

author = "Goodman, {Phyllis J.} and Tangen, {Catherine M.} and Crowley, {John J.} and Carlin, {Susan M.} and Anne Ryan and Coltman, {Charles A.} and Ford, {Leslie G.} and Thompson, {Ian M.}",

year = "2004",

month = apr,

doi = "10.1016/j.cct.2003.11.007",

language = "English (US)",

volume = "25",

pages = "203--222",

journal = "Controlled Clinical Trials",

issn = "0197-2456",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Implementation of the Prostate Cancer Prevention Trial (PCPT)

AU - Goodman, Phyllis J.

AU - Tangen, Catherine M.

AU - Crowley, John J.

AU - Carlin, Susan M.

AU - Ryan, Anne

AU - Coltman, Charles A.

AU - Ford, Leslie G.

AU - Thompson, Ian M.

PY - 2004/4

Y1 - 2004/4

N2 - The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.

AB - The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.

KW - Chemoprevention

KW - Finasteride

KW - Prostate cancer

KW - Study management

KW - Study organization

UR - http://www.scopus.com/inward/record.url?scp=1542321126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542321126&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2003.11.007

DO - 10.1016/j.cct.2003.11.007

M3 - Article

C2 - 15020037

AN - SCOPUS:1542321126

VL - 25

SP - 203

EP - 222

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

SN - 0197-2456

IS - 2

ER -